A case report describing myocardial ischaemia as a side effect of carbamazepine overdose
- PMID: 39345958
- PMCID: PMC11437652
- DOI: 10.1093/ehjcr/ytae488
A case report describing myocardial ischaemia as a side effect of carbamazepine overdose
Abstract
Background: Overdoses of carbamazepine may occur due to various reasons. The summary of product characteristics of carbamazepine includes information about the possibility of side effects after taking this drug. However, the symptoms described do not include coronary vasospasm, which occurred in the case described. Making such a diagnosis is a key element in therapeutic management, as it changes further clinical decisions.
Case summary: A 46-year-old patient was admitted to the hospital for disorders of consciousness following an overdose of carbamazepine. On the second day, the patient exhibited respiratory distress. Subsequently, the patient was transferred to the intensive care unit, intubated, and placed on mechanical ventilation. On the same day, the patient experienced recurrent cardiac arrhythmias in the form of pulseless ventricular tachycardia and ventricular fibrillation; the patient was resuscitated and defibrillated eight times. Due to a rapid decline in cardiac output coupled with persistent electrocardiographic changes and haemodynamic instability, the patient underwent urgent coronary angiography. The procedure revealed a spasm in the initial segment of the circumflex branch of the left coronary artery, which subsequently resolved following nitroglycerin administration. Subsequent to the implementation of this therapeutic approach, a reduction in the demand for norepinephrine and dobutamine was achieved. In the following days, the patient's general condition improved. The patient was discharged home while maintaining full cognitive capacity and cardiovascular and respiratory fitness.
Discussion: In the case described, the expeditious performance of a cardiological diagnostic evaluation played a pivotal role in achieving therapeutic success, enabling the prompt initiation of appropriate treatment.
Keywords: Arrhythmia; Carbamazepine; Case report; Coronary artery spasm; Intoxication.
© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.
Conflict of interest statement
Conflict of interest. None declared.
Figures



References
-
- Alrashood ST. Carbamazepine. Profiles Drug Subst Excip Relat Methodol 2016;41:133–321. - PubMed
-
- Martins IL, Nunes J, Charneira C, Morello J, Pereira SA, Telo JP, et al. . The first-line antiepileptic drug carbamazepine: reaction with biologically relevant free radicals. Free Radic Biol Med 2018;129:559–568. - PubMed
-
- POLPHARMA SA. Characteristics of the medicinal product. Available from: http://chpl.com.pl/data_files/2010-03-03_smpc_amizepin_pph_2010_01p.pdf (28 August 2024).
-
- Qureshi WM, Memon S, Latif ML, Garle MJ, Parker TL, Pratten MK. Carbamazepine toxic effects in chick cardiomyocyte micromass culture and embryonic stem cell derived cardiomyocyte systems—possible protective role of antioxidants. Reprod Toxicol 2014;50:49–59. - PubMed
Publication types
LinkOut - more resources
Full Text Sources